Status:
UNKNOWN
Monocentric Registry to Investigate the Role of Platelet Function, Platelet Genetics, Proteomics and Metabonomics in Heart Disease
Lead Sponsor:
University Hospital Tuebingen
Collaborating Sponsors:
National Heart and Lung Institute
Royal Brompton & Harefield NHS Foundation Trust
Conditions:
Cardiovascular Disease
Eligibility:
All Genders
18+ years
Brief Summary
Molecular targets on platelets are pivotal for the development of new pharmacological substrates for platelet inhibition and to better understand the impact of platelet-mediated inflammatory processes...
Eligibility Criteria
Inclusion
- Patients with ischemic and non-ischemic heart disease
- informed consent by patients or relatives in case of missing capacity to consent due to health status
Exclusion
- Patients \<18 years
- missing informed consent
Key Trial Info
Start Date :
January 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
3000 Patients enrolled
Trial Details
Trial ID
NCT01417884
Start Date
January 1 2012
End Date
December 1 2025
Last Update
October 15 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medizinische Klinik und Poliklinik Tübingen, Cardiology Department, University Hospital Tübingen
Tübingen, Baden-Wurttemberg, Germany, 72076